Does maladaptive cardiovagal modulation extend to gastric modulation in women with chronic pelvic pain?
DeWayne Williams1, Eric Muth2, Julian Thayer1
1Department of Psychological Science, University of California, Irvine, California, USA.
Background:
Women with chronic pelvic pain (CPP) have poor cardiovagal modulation. It is unclear whether this finding reflects a broader abnormality across many systems such as gastro-vagal modulation.
Aim:
To determine if maladaptive cardiovagal activity in females with CPP is accompanied by maladaptive gastric myoelectric activity.
Methods:
A total of 36 health controls (HC) and 75 CPP underwent supine (10 min), then upright (tilted 70° head up; 30 min), and back to supine (10 min) positions. High-frequency heart rate variability (HF-HRV; 0.15-0.4 Hz) was measured as an index of cardiovagal activity. Cutaneous electrogastrography (EGG) assessed gastric myoelectric activity pre- and during-upright tilt. EGG measures from 16 HC and 31 CPP patients were available for analysis and included relative percentage of gastric activity within the normal (2-4 cpm) and tachygastria (4-10 cpm) ranges, plus ratio of normal/tachygastria.
Results:
HF-HRV was lower in CPP individuals at all time points (each p < .05). CPP individuals showed lesser decrease in HF-HRV from supine to upright, and poorer HF-HRV recovery from upright back to supine (F[1, 106] = 4.62, p = .034). HC showed increase in tachygastria activity (t[15] = -2.09, p = .054) while the CPP group showed no change in tachygastria activity from pre-upright to upright (t[30] = -0.62, p = .537).
Conclusions:
Individuals with CPP going from supine to upright demonstrate an impairment in both tachygastria and the parallel decrement in HRV. These results support the hypothesis of a generalized blunting in the physiological modulation in CPP individuals affecting both cardiovascular and gastric systems.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Mitral Valve Prolapse III: Nursing Management
Cardiomyopathy VI: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Valve Prolapse II: Assessment and Management
Cardiomyopathy V: Interprofessional Care


